The Lack of Systemic and Subclinical Side Effects of Botulinum Neurotoxin Type-A in Patients Affected by Post-Stroke Spasticity: A Longitudinal Cohort Study
Marco Battaglia(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Alessio Baricich(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Alessandro Picelli(University of Verona), Alberto Loro(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Claudio Molinari(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Francesca Uberti(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Andrea Santamato(University of Foggia), Margherita Beatrice Borg(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Marco Invernizzi(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Lara Torgano(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”), Stefano Carda(University Hospital of Lausanne), Lucia Cosenza(Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo), Michele Bertoni(Aziende Socio Sanitarie Territoriale dei Sette Laghi)
Cited by 3
Related Papers
Pathophysiology of Motor Dysfunction in Parkinson’s Disease as the Rationale for Drug Treatment and Rehabilitation
|Parkinson s Disease|2016|374
Virtual Reality Telerehabilitation for Postural Instability in Parkinson’s Disease: A Multicenter, Single-Blind, Randomized, Controlled Trial
|BioMed Research International|2017|325
1α,25-Dihydroxycholecalciferol Induces Nitric Oxide Production in Cultured Endothelial Cells
|Cellular Physiology and Biochemistry|2011|202
Rehabilitation procedures in the management of spasticity.
|PubMed|2010|168